CD19-CD22-bispecific CAR-T cell therapy

· St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CD19-CD22-bispecific CAR-T cell therapy, covering 2025-12-04 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma [Phase 2]